ArticleTropical medicine and health2026
Dengue virus serotype 4-leading serotype epidemic and its clinical and molecular characteristics in Vung Tau, South Vietnam, 2020-2021.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
Abstract
Dengue cases are reported annually in Vung Tau province, southern Vietnam; however, data on viral and host factors associated with disease severity are limited, particularly during epidemics driven by specific serotypes. We investigated the prevalence of dengue virus (DENV), its molecular epidemiology, and clinical-laboratory correlates of severity in patients with suspected dengue at Vung Tau General Hospital between September 2020 and May 2021. Among 1435 suspected cases, 639 (44.5%) were classified as DENV infection-negative, 60 (4.2%) presented with primary infection and 736 (51.3%) with secondary infection. DENV serotyping indicated that DENV-4 was the most prevalent serotype (50 patients, 37.6%), followed by DENV-2 (41, 30.8%), DENV-1 (39, 29.3%), and DENV-3 (3, 2.3%). Phylogenetic analysis revealed DENV-1 genotype I, DENV-2 genotype II (cosmopolitan) and genotype V (Asian I), and DENV-4 genotype I. Notably, DENV-4 exhibited two coexisting clades, suggesting that variations in clade distribution may have contributed to the epidemic. Although parameters commonly associated with dengue severity, such as white blood cell counts, platelet counts, and liver enzyme levels (AST and ALT), were comparable across serotypes, hemoglobin and hematocrit levels were elevated in DENV-4 infections compared with other serotypes. This elevation may indicate a higher risk of plasma leakage, a key feature of severe dengue, underscoring the potential clinical significance of DENV-4 during this epidemic. These findings highlight the epidemiological and clinical importance of DENV-4 and provide evidence for refining dengue control strategies in endemic areas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.